Abstract: Disclosed in the present invention are a dynamic maximal clique enumeration device and method based on an FPGA with an HBM, the method including: the HBM stores a dynamic edge flow, a complete graph adjacency matrix, and candidate cliques; a matrix computing unit updates the complete graph adjacency matrix based on the dynamic edge flow, transmits the updated complete graph adjacency matrix to the HBM for storage, and determines header nodes, of which the corresponding candidate clique needs to be updated; a sequence computing unit constructs, according to the updated complete graph adjacency matrix and each header node to be updated, the sorted data set for reconstructing candidate cliques by data block sequencing; and an update computing unit executes, in parallel, an update task of the candidate clique corresponding to each header node to be updated based on the sorted data set, transmits the updated candidate cliques to the HBM for storage, and transmits the updated candidate cliques to the PC host to ext

Abstract: Provided is a CD8? binding polypeptide. The CD8? binding polypeptide contains at least one variable domain, and compared with an amino acid sequence as represented by SEQ ID NO:1, the amino acid sequence of the variable domain has substitutions, deletions or additions of one or several amino acids. Further provided are a composition containing the CD8? binding polypeptide and the use thereof in the diagnosis and/or treatment of various diseases including, for example, tumors.

Abstract: Systems, methods, devices and storage media for graph data processing are provided. In one aspect, a graph data processing system includes a memory and a plurality of processing units, and each processing unit is provided with a decision module. Each processing unit is configured to determine set operations required for extracting one or more subgraphs matching a specified graph pattern from target graph data according to a preset graph pattern matching algorithm. Then, for each set operation, the decision module is configured to determine a cost value corresponding to a performance of the processing unit occupied to execute the set operation in accordance with different execution policies, and further select a target execution policy with a smallest cost value to execute the set operation.

Abstract: The present invention relates to the field of biological medicines. Specifically, the present invention relates to a specific CD8 binding polypeptide and use thereof.

Abstract: The present invention relates to energy-efficient collaborative method and apparatus for graph processing, wherein the apparatus comprises at least: a dependency path prefetching unit for receiving active vertex information and prefetching an edge of graph partition along a dependency path, starting with an active vertex in a circular queue; and a direct dependency managing unit for converting dependency relationship between head and tail vertices of a core dependency path into direct dependency and managing it in a cache, and updating dependency indexes according to dynamic changes in graph structure during dynamic graph processing, so as to ensure accurate results of graph processing. The accelerator of the present invention is capable of being integrated into a multi-core processor, thereby processing multiple paths on multiple processor kernels with high concurrency, and in turn accelerating dissemination of vertex states in a graph to speed convergence during graph processing.

Abstract: The invention relates to the field of biomedicine. Specifically, the invention relates to a specific PD-L1 binding polypeptide and uses thereof in particular, uses m detecting and/or diagnosing PD-L1 related diseases such as cancers.

Abstract: Embodiments of the present disclosure provide a method, system and network node for auto-configuration, and a network node. A network node in a BVLAN receives IS-IS protocol packets sent by other network nodes in the BVLAN; determines its own priority in the BVLAN; transmits uniform configuration information in the BVLAN according to its own priority, where the uniform configuration information is information that needs to be configured on each network node in the BVLAN. In the embodiments of the present disclosure, auto-configuration may be performed on the network node, thereby improving a speed and accuracy of configuration.

Abstract: A device for treatment of premature ejaculation or stimulation of a male organ includes an elastic sleeve mounted within a housing, at least one aperture formed on the elastic sleeve, and at least one liquid-absorbing member held between the housing and the elastic sleeve over the at least one aperture. The at least one liquid-absorbing member is adapted to soak up a liquid with a temperature higher or lower than the body temperature of a user and deliver the liquid through the at least one aperture and into the elastic sleeve when the at least one liquid-absorbing member is squeezed by a male organ of the user frictionally moving to-and-fro inside the elastic sleeve, thereby stimulating the male organ and reducing the sensitivity thereof.

Abstract: A method for the production of cellulose films with at least one hydrophobic or less hydrophilic surface, or with at least one surface with a water contact angle (?) in a range from 55° to less than 100° is described. The method involves contacting the cellulose material with a hydrophobic solid material during the preparation of the cellulose films or with a vapour of a non-polar or polar aprotic solvent during or after the preparation of the cellulose films. Examples of the cellulose material are cellulose filaments (CF) made to have at least 50% by weight of the filaments having a filament length up to 350 ?m and a filament diameter between 100 and 500 nm from multi-pass, high consistency refining of wood or plant fibers, and commercially-available sodium carboxymethyl cellulose. Examples of the hydrophobic solid material are hydrophobic polymers, poly(methylpentene) and poly(ethylene). Examples of the non-polar solvent are hexane and toluene.

Abstract: The present invention describes a composition and a method for producing mesoporous silica materials with a chiral organization. In the method, a polymerizable inorganic monomer is reacted in the presence of nanocrystalline cellulose (NCC) to give a material of inorganic solid with cellulose nanocrystallites embedded in a chiral nematic organization. The NCC can be removed to give a stable porous structure that retains the chiral organization of the NCC template. The new materials may be obtained as iridescent free-standing films with high surface area. Through control of the reaction conditions, the color of the films can be varied across the entire visible spectrum. These are the first materials to combine mesoporosity with long-range chiral ordering that leads to photonic properties.

Abstract: Embodiments of the present disclosure provide a method, system and network node for auto-configuration, and a network node. A network node in a BVLAN receives IS-IS protocol packets sent by other network nodes in the BVLAN; determines its own priority in the BVLAN; transmits uniform configuration information in the BVLAN according to its own priority, where the uniform configuration information is information that needs to be configured on each network node in the BVLAN. In the embodiments of the present disclosure, auto-configuration may be performed on the network node, thereby improving a speed and accuracy of configuration.

Abstract: Nematic liquid crystal cells with positive dielectric anisotropy that include colloidal suspensions having nanoclusters are provided as well as methods of inducing Freedericksz transitions therein and methods of controlling the alignment of a liquid crystal.

Abstract: The present invention relates to mouse and human J12 polynucleotides, polypeptide and anti J12 antibody molecules. The J12 is a cytokine that is preferentially expressed in Th2 cells. The polypeptides and/or antibodies described herein can be used in methods for detection and treatment of certain autoimmune and inflammatory diseases including asthma.

Abstract: A device for treatment of premature ejaculation or stimulation of a male organ includes an elastic sleeve mounted within a housing, at least one aperture formed on the elastic sleeve, and at least one liquid-absorbing member held between the housing and the elastic sleeve over the at least one aperture. The at least one liquid-absorbing member is adapted to soak up a liquid with a temperature higher or lower than the body temperature of a user and deliver the liquid through the at least one aperture and into the elastic sleeve when the at least one liquid-absorbing member is squeezed by a male organ of the user frictionally moving to-and-fro inside the elastic sleeve, thereby stimulating the male organ and reducing the sensitivity thereof.

Abstract: The invention provides a metal nanoparticle comprising a metal and a chiral and/or thiolate group bonded to the metal. The monolayer-protected metal nanoparticle may be used as a chiral dopant in a liquid crystal. Accordingly, the invention also provides a colloidal suspension or dispersion comprising a metal nanoparticle comprising a metal and a chiral and/or thiolate group bonded to the metal, and a liquid crystal.

Abstract: The present invention describes a composition and a method for producing mesoporous silica materials with a chiral organization. In the method, a polymerizable inorganic monomer is reacted in the presence of nanocrystalline cellulose (NCC) to give a material of inorganic solid with cellulose nanocrystallites embedded in a chiral nematic organization. The NCC can be removed to give a stable porous structure that retains the chiral organization of the NCC template. The new materials may be obtained as iridescent free-standing films with high surface area. Through control of the reaction conditions, the colour of the films can be varied across the entire visible spectrum. These are the first materials to combine mesoporosity with long-range chiral ordering that leads to photonic properties.

Abstract: Nematic liquid crystal cells with positive dielectric anisotropy that include colloidal suspensions having nanoclusters are provided as well as methods of inducing Freedericksz transitions therein and methods of controlling the alignment of a liquid crystal.

Abstract: The present invention relates to mouse and human J12 polynucleotides, polypeptide and anti J12 antibody molecules. The J12 is a cytokine that is preferentially expressed in Th2 cells. The polypeptides and/or antibodies described herein can be used in methods for detection and treatment of certain autoimmune and inflammatory diseases including asthma.

Abstract: The invention provides a metal nanoparticle comprising a metal and a chiral and/or thiolate group bonded to the metal. The monolayer-protected metal nanoparticle may be used as a chiral dopant in a liquid crystal. Accordingly, the invention also provides a colloidal suspension or dispersion comprising a metal nanoparticle comprising a metal and a chiral and/or thiolate group bonded to the metal, and a liquid crystal.

Abstract: A sliding mechanism and a display device using the same are provided. The display device is supported by a supporting structure. The sliding mechanism comprises a sliding track, a slider, an elastic element and a fixing prop. The sliding track is disposed on the display device. The slider is movably disposed on the sliding track. The elastic element has a winding portion disposed at one end of the sliding track and an extended end connected to the slider and simultaneously movable with the slider. The fixing prop is disposed on the slider for connecting the slider with the supporting structure. When the slider slides along the sliding track, the display device moves relative to the supporting structure for adjusting the height of the display device accordingly. The elastic element provides the slider with a constant force whose direction is opposite to that of the gravity of the display device.